Literature DB >> 10964971

Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials.

G J LaHoste1, B L Henry, J F Marshall.   

Abstract

The widespread biological actions of the neurotransmitter dopamine (DA) are mediated by two classes of receptor, the D(1) class (D(1) and D(5)) and the D(2) class (D(2), D(3), and D(4)), which interact synergistically in many paradigms, such as DA agonist-stimulated motor behavior and striatal c-fos expression. Understanding the mechanism(s) of this interaction has been impeded by a controversy regarding the cellular localization of D(1) and D(2) class receptors. To address this issue from a functional point of view, we elicited striatal Fos by combined administration of a D(1) class and a D(2) class agonist either in the presence or absence of the fast sodium channel blocker tetrodotoxin (TTX). Striatal Fos elicited by direct D(1)/D(2) stimulation was not reduced by TTX. By contrast, TTX greatly attenuated the Fos response evoked by cocaine or GBR 12909. In separate experiments using antagonists that distinguish among members of the D(2) class of receptors, amphetamine-stimulated Fos and motor behavior were attenuated dose-dependently by the selective D(2) antagonist L-741,626, but not by the selective D(3) antagonist U99194A or the D(4)-selective antagonist L-745,870. Because Fos expression in the paradigms that were used occurs in enkephalin-negative striatonigral neurons, which show limited coexpression of D(1) and D(2) receptors, the present findings taken together suggest the intriguing possibility that D(1)/D(2) synergism may be mediated by D(1) and D(2) receptors residing on separate striatal neurons and interacting in a manner that is not dependent on action potentials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964971      PMCID: PMC6772947     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain.

Authors:  J H Meador-Woodruff; A Mansour; D J Healy; R Kuehn; Q Y Zhou; J R Bunzow; H Akil; O Civelli; S J Watson
Journal:  Neuropsychopharmacology       Date:  1991-12       Impact factor: 7.853

3.  Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.

Authors:  K M Merchant; L M Figur; D L Evans
Journal:  Cereb Cortex       Date:  1996 Jul-Aug       Impact factor: 5.357

4.  Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Authors:  M Xu; T E Koeltzow; G T Santiago; R Moratalla; D C Cooper; X T Hu; N M White; A M Graybiel; F J White; S Tonegawa
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

5.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

6.  D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.

Authors:  G S Robertson; S R Vincent; H C Fibiger
Journal:  Neuroscience       Date:  1992-07       Impact factor: 3.590

7.  In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids.

Authors:  K A Keefe; M J Zigmond; E D Abercrombie
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  Distribution of mRNAs coding for liver and heart gap junction proteins in the rat central nervous system.

Authors:  P E Micevych; L Abelson
Journal:  J Comp Neurol       Date:  1991-03-01       Impact factor: 3.215

9.  Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.

Authors:  M J Heeringa; E D Abercrombie
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

10.  Dye coupling between rat striatal neurons recorded in vivo: compartmental organization and modulation by dopamine.

Authors:  S P Onn; A A Grace
Journal:  J Neurophysiol       Date:  1994-05       Impact factor: 2.714

View more
  20 in total

1.  Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats.

Authors:  Soledad Cabeza de Vaca; Xing-Xiang Peng; Seth Concors; Casey Farin; Elena Lascu; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2011-12-07       Impact factor: 4.530

2.  Harmful algal bloom toxins alter c-Fos protein expression in the brain of killifish, Fundulus heteroclitus.

Authors:  J D Salierno; N S Snyder; A Z Murphy; M Poli; S Hall; D Baden; A S Kane
Journal:  Aquat Toxicol       Date:  2006-05-01       Impact factor: 4.964

3.  The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents.

Authors:  Suhail Kasim; Bonita L Blake; Xueliang Fan; Elena Chartoff; Kiyoshi Egami; George R Breese; Ellen J Hess; H A Jinnah
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

4.  Dopamine stimulation of postnatal murine subventricular zone neurogenesis via the D3 receptor.

Authors:  Yongsoo Kim; Wei-Zhi Wang; Isabelle Comte; Erika Pastrana; Phuong B Tran; Jennifer Brown; Richard J Miller; Fiona Doetsch; Zoltán Molnár; Francis G Szele
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

5.  Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons.

Authors:  Alexander B Wiltschko; Jeffrey R Pettibone; Joshua D Berke
Journal:  Neuropsychopharmacology       Date:  2010-01-20       Impact factor: 7.853

6.  Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

Authors:  Natacha Vanattou-Saïfoudine; Ruth McNamara; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2010-05-02       Impact factor: 4.530

7.  New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease.

Authors:  Young-Cho Kim; Stephanie L Alberico; Eric Emmons; Nandakumar S Narayanan
Journal:  Front Biol (Beijing)       Date:  2015-05-13

8.  Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats.

Authors:  Jun Gao; Yonghui Li; Ning Zhu; Stephen Brimijoin; Nan Sui
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

9.  Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.

Authors:  Ekaterina Boudanova; Deanna M Navaroli; Haley E Melikian
Journal:  Neuropharmacology       Date:  2007-11-22       Impact factor: 5.250

10.  Increased temporal patterns in choice responding and altered cognitive processes in schizophrenia and mania.

Authors:  Melvin Lyon; Aaron S Kemp
Journal:  Psychopharmacology (Berl)       Date:  2003-10-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.